Suchergebnisse - "Personeni, Nicola"

PubPharm (10)

1

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von Vithayathil, M. | D'Alessio, A. | Fulgenzi, C. | +32

CommentIn: Liver Int. 2022 Nov;42(11):2352-2353. - PMID 36162086

2

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice : Results of the AB-real study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Fulgenzi, C. | Cheon, J. | D'Alessio, A. | +34

3

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis : A real-world study

enthalten in: Hepatology (Baltimore, Md.) | 2022

von D'Alessio, A. | Fulgenzi, C. | Nishida, N. | +32

CommentIn: Hepatology. 2022 Oct;76(4):906-908. - PMID 35491442

4

Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma : shedding light on the preclinical rationale and clinical trials

enthalten in: Expert opinion on investigational drugs | 2022

von Cammarota, A. | Zanuso, V. | D'Alessio, A. | +3

5

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score

enthalten in: Journal of hepatology | 2022

von Scheiner, B. | Pomej, K. | Kirstein, M. | +38

CommentIn: J Hepatol. 2022 Apr;76(4):987-988. - PMID 34780876

6

Shaping the landscape of immune oncology in hepatocellular carcinoma

enthalten in: The Lancet. Oncology | 2018

von Personeni, N. | Rimassa, L.

CommentOn: Lancet Oncol. 2018 Jul;19(7):940-952. - PMID 29875066

7

Fatal infusion reaction to cetuximab : the need for predictive risk factors and safer patient selection

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2011

von Tronconi, M. | Sclafani, F. | Rimassa, L. | +3

CommentIn: J Clin Oncol. 2012 Jan 20;30(3):334; author reply 335. - PMID 22162592

8

Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab : a fluorescent in situ hybridization study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2008

von Personeni, N. | Fieuws, S. | Piessevaux, H. | +11

9

Achievements in systemic therapies in the pregenomic era in metastatic breast cancer

enthalten in: The oncologist | 2007

von Colozza, M. | de Azambuja, E. | Personeni, N. | +3

10

Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer

enthalten in: Seminars in oncology | 2005

von Personeni, N. | Hendlisz, A. | Gallez, J. | +8

1
[1]